Impact of Chronic Kidney Disease on Outcomes of Superficial Femoral Artery Endoluminal Interventions

Andrew M. Bakken, Clinton D. Protack, Wael E. Saad, Joseph P. Hart, Jeffrey M. Rhodes, David L. Waldman, Mark G. Davies

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


While aggressive endoluminal therapy for superficial femoral artery (SFA) occlusive disease is commonplace, the implications of chronic kidney disease (CKD) on long-term outcomes in this population are unclear. We examined the consequences of endovascular treatment of the SFA in patients with and without varying stages of CKD. A database of patients undergoing endovascular treatment of the SFA between 1986 and 2007 was queried, and two groups were defined: estimated glomerular filtration rate (eGFR) ≤60 and >60 mL/min/1.73 cm2. Intention-to-treat analysis was performed. Results were standardized to TransAtlantic Inter-Society Consensus (TASC-II) and Society for Vascular Surgery criteria. Kaplan-Meier analyses were performed to assess time-dependent outcomes. Factor analyses were performed using a Cox proportional hazard model for time-dependent variables. Data are presented as mean ± standard deviation where appropriate. There were 525 limbs in 535 patients (68% male, average age 66 ± 14 years) that underwent endovascular treatment for claudication or chronic critical limb ischemia (51%). Patients with eGFR ≤60 were older and had significantly more coronary artery disease, congestive heart failure, diabetes mellitus, and hyperlipidemia. TASC-II lesion distribution was equivalent (37% for TASC-II C and D), but tibial runoff was significantly worse in the eGFR ≤60 group. In addition, there were more inflow and outflow interventions in the eGFR ≤60 group. In patients with claudication, there was no difference in patency or limb salvage between those with eGFR ≤60 and >60. In patients with critical limb ischemia, there was no difference in patency between those with eGFR ≤60 and >60. Limb salvage was worse in patients with eGFR ≤60 compared to eGFR >60. With respect to limb salvage, six factors were significantly associated with a reduction in rates: presence of tissue loss at presentation (relative risk [RR] = 6.45, p = 0.003), 0 or 1 vessel tibial runoff (RR = 2.56, p < 0.01), progression of distal disease noted in follow-up (RR = 4.62, p < 0.01), embolization at the initial intervention (RR = 2.70, p < 0.05), diabetes mellitus (RR = 3.71, p < 0.01), and a history of congestive heart disease (RR = 2.42, p < 0.01). Notable factors that were not significantly associated included lesion calcification (p = 0.64), TASC C or D lesion categorization (p = 0.99), acute occlusion at initial intervention (p = 0.40), and adjuvant stenting (p = 0.67). CKD does not impact the patency of SFA interventions. Limb salvage in patients with critical ischemia is significantly worse when the eGFR is ≤60 mL/min/1.73 cm2.

Original languageEnglish (US)
Pages (from-to)560-568
Number of pages9
JournalAnnals of Vascular Surgery
Issue number5
StatePublished - Sep 2009

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Impact of Chronic Kidney Disease on Outcomes of Superficial Femoral Artery Endoluminal Interventions'. Together they form a unique fingerprint.

Cite this